Shares of both Ultragenyx and Mereo BioPharma were seeing record selloffs after disappointing trial results for setrusumab.

A new discovery about osteoporosis suggests a potential treatment target for that brittle-bone disease and for bone loss from rheumatoid arthritis. The findings from University of Virginia School of ...

Novosteo Inc. will use funding to advance development of NOV004 for the treatment of bone fractures, other bone diseases and support Phase 1 clinical trials Novosteo Inc., a preclinical-stage ...

Novosteo Inc. will use funding to advance development of NOV004 for the treatment of bone fractures, other bone diseases and support Phase 1 clinical trials. WEST LAFAYETTE, Ind. – Novosteo Inc., a ...

A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine at the University of ...

Ultragenyx Pharmaceutical said on Monday that late-stage studies showed its drug for a type of genetic bone disease failed to ...

Bone health during breast cancer treatment can be a concern, but there are ways to reduce the impact. If a person is at risk for a loss of bone density, doctors can prescribe medications. Lifestyle ...

A new discovery about osteoporosis suggests a potential treatment target for that brittle-bone disease and for bone loss from rheumatoid arthritis. A new discovery about osteoporosis suggests a ...

A University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their metabolism to thrive in bone tissue, offering a potential new treatment target for patients with ...